Trump administration officials including Health Secretary Robert F. Kennedy Jr. have discussed scaling back the role of Marty Makary, the Food and Drug Administration commissioner

The recent discussions among Trump administration officials, including Health Secretary Robert F. Kennedy Jr., about scaling back FDA Commissioner Marty Makary's role highlight ongoing tensions within the administration regarding public health leadership. This comes amid a backdrop of personal revelations, such as political reporter Olivia Nuzzi's accounts of her romantic relationship with Kennedy Jr., which may influence public perception of his leadership. As Kennedy Jr. contemplates appointing a new FDA leader, the implications for health policy and agency direction remain significant.